Strong Performance for T-Mobile, AstraZeneca, and Comcast in Latest Analyst Reports

Today’s Research Daily from Zacks highlights new reports on 16 major stocks, including T-Mobile US, Inc. (TMUS), AstraZeneca PLC (AZN), and Comcast Corp. (CMCSA). T-Mobile’s shares have outperformed the industry, benefiting from postpaid customer growth and a strong acquisition strategy. AstraZeneca’s key drugs are expected to drive revenues, but lower sales in China may impact performance. Comcast is facing challenges due to video-subscriber attrition, but its streaming service Peacock is driving broadband sales. For full research reports on these companies and more, visit Zacks.com.

Read more at Zacks Investment Research: Top Analyst Reports for T-Mobile, AstraZeneca & Comcast – July 8, 2025